FindTrial
Sign In

The prevalence of magnesium deficiency after liver transplantation, risk factors and prediction tool

The prevalence of magnesium deficiency after liver transplantation, risk factors and prediction tool

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ECS-12002434
Enrollment
Unknown
Registered
2012-08-18
Start date
2012-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

transplant recipient, magnesium deficiency

Interventions

1:no

Sponsors

The General Hospital of Chinese People's Armed Police Forces
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Liver transplant recipient; 2. Age of 20-70 years; 3. Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation; 2. Other organ transplantation; 3. Patients,who use drug magnesium 1 months before the beginning of the study; 4. Patients with delirium or dementia, who cannot obtain informed consent; 5. Not suitable for clinical trials because of other reasons.

Design outcomes

Primary

MeasureTime frame
Serum magnesium;—

Secondary

MeasureTime frame
Vitamin D levels;Calcineurin inhibitors levels;Blood glucose;Insulin in serum;Electrolytes;Renal function;Liver function;—

Countries

China

Contacts

Public ContactShen Zhongyang
niuyujian@yahoo.com.cn+86 10 57976840

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026